SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999371-24-004225
Filing Date
2024-03-29
Accepted
2024-03-29 17:16:46
Documents
23
Period of Report
2024-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-032824.htm   iXBRL 8-K 50667
2 PLACEMENT AGENT AGREEMENT ex1-01.htm EX-1.01 76645
3 FORM OF PRE-FUNDED WARRANT ex4-01.htm EX-4.01 100244
4 FORM OF SERIES E WARRANT ex4-02.htm EX-4.02 84269
5 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 19958
6 OPINION OF LOWENSTEIN SANDLER LLP ex5-02.htm EX-5.02 11263
7 FORM OF SECURITIES PURCHASE AGREEMENT ex10-01.htm EX-10.01 315961
8 FORM OF WARRANT AMENDMENT AGREEMENT ex10-02.htm EX-10.02 18711
9 PRESS RELEASE, DATED MARCH 28, 2024 ex99-01.htm EX-99.01 14446
13 GRAPHIC brownsteinlogo.jpg GRAPHIC 13918
14 GRAPHIC ex5-2_img001.jpg GRAPHIC 8290
  Complete submission text file 0001999371-24-004225.txt   1047366

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE tnxp-20240328.xsd EX-101.SCH 3024
11 XBRL LABEL FILE tnxp-20240328_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE tnxp-20240328_pre.xml EX-101.PRE 22365
26 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-032824_htm.xml XML 3547
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 24804804
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)